Related Experiment Video

Updated: Nov 21, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.4K

Thromboembolism in Patients with Hypertrophic Cardiomyopathy

Lu Liu1, Zheng Liu2, Xiaoping Chen1

  • 1Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.

International Journal of Medical Sciences
|January 13, 2021
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) patients face high risks of thromboembolic events like stroke. New predictive models are needed to identify these risks early and prevent serious outcomes.

Area of Science:

  • Cardiology
  • Genetics
  • Thrombosis

Background:

  • Hypertrophic cardiomyopathy (HCM) is an inherited cardiac condition with varied clinical outcomes.
  • HCM patients have a high incidence of thromboembolic events (stroke, systemic emboli), independent of atrial fibrillation (AF).
  • Existing risk models for thromboembolism in HCM are inadequate.

Purpose of the Study:

  • To address the limitations of current thromboembolic risk prediction in hypertrophic cardiomyopathy.
  • To explore novel models for accurate risk stratification of thromboembolic events in HCM patients.
  • To improve early identification and prevention strategies for thromboembolism in HCM.

Main Methods:

  • Review of existing literature on hypertrophic cardiomyopathy and thromboembolic risk factors.
  • Analysis of established thromboembolic predictive models in the context of HCM.
  • Exploration of potential modifications or development of new predictive models tailored for HCM.

Main Results:

  • Hypertrophic cardiomyopathy is linked to a significant prevalence of thromboembolic events.
  • Established risk factors for thromboembolism include AF, age, left atrial diameter, and heart failure.
  • Current predictive models demonstrate limitations in accurately stratifying HCM patients.

Conclusions:

  • Accurate risk stratification for thromboembolism is crucial in HCM management.
  • Development of novel, HCM-specific predictive models is warranted.
  • Timely preventive measures and aggressive management are essential to mitigate thromboembolic risks in HCM.

Keywords:
anticoagulant therapyatrial fibrillationhypertrophic cardiomyopathystrokethromboembolism

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.9K
Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.2K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
149
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
124
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
152
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
118
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
127
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
215